Home > Insider Trading > Filing (0001567619-19-008334)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
894158	Synthetic Biologics Inc.	SYN	Pharmaceutical Preparations (2834)	133808303

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1091823	J Randal Kirk	C/O Third Security, Llc 1881 Grove Avenue Radford VA 24141		No	No	Yes	No
1356090	Intrexon Corp	C/O Legal Department 20374 Seneca Meadows Parkway Germantown MD 20876		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-04-01	11,413	$0.67	92,159	No	4	S	Indirect	by NRM VII Holdings
Common Stock	Disposition	2019-04-01	30,265	$0.67	244,402	No	4	S	Indirect	by Intrexon
Common Stock	Disposition	2019-04-02	3,737	$0.66	88,422	No	4	S	Indirect	by NRM VII Holdings
Common Stock	Disposition	2019-04-02	9,909	$0.66	234,493	No	4	S	Indirect	by Intrexon
Common Stock	Disposition	2019-04-03	26,080	$0.65	62,342	No	4	S	Indirect	by NRM VII Holdings
Common Stock	Disposition	2019-04-03	69,161	$0.65	165,332	No	4	S	Indirect	by Intrexon

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	by NRM VII Holdings
No	4	S	Indirect	by Intrexon
No	4	S	Indirect	by NRM VII Holdings
No	4	S	Indirect	by Intrexon
No	4	S	Indirect	by NRM VII Holdings
No	4	S	Indirect	by Intrexon

Footnotes

Pursuant to a joint selling program, NRM VII Holdings I, LLC ("NRM VII Holdings") and Intrexon Corporation ("Intrexon") sold shares on a pro rata basis.
The indicated share amount is reflective of a 1:35 reverse stock split effected by the issuer on August 10, 2018.
Randal J. Kirk controls NRM VII Holdings. Shares held by this entity may be deemed to be indirectly beneficially owned (as defined under Rule 13d- 3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Randal J. Kirk, directly and through certain affiliates, is the largest shareholder of Intrexon and serves as Intrexon's Chairman of the Board and Chief Executive Officer. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon. Shares held by Intrexon may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.